192 related articles for article (PubMed ID: 23388418)
1. HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.
Liu J; Zhu LP; Yang XL; Huang HL; Ye DQ
Bone; 2013 May; 54(1):151-6. PubMed ID: 23388418
[TBL] [Abstract][Full Text] [Related]
2. Effects of statins on bone mineral density: a meta-analysis of clinical studies.
Uzzan B; Cohen R; Nicolas P; Cucherat M; Perret GY
Bone; 2007 Jun; 40(6):1581-7. PubMed ID: 17409043
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
An T; Hao J; Sun S; Li R; Yang M; Cheng G; Zou M
Osteoporos Int; 2017 Jan; 28(1):47-57. PubMed ID: 27888285
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients.
Chung YS; Lee MD; Lee SK; Kim HM; Fitzpatrick LA
J Clin Endocrinol Metab; 2000 Mar; 85(3):1137-42. PubMed ID: 10720052
[TBL] [Abstract][Full Text] [Related]
5. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
Hatzigeorgiou C; Jackson JL
Osteoporos Int; 2005 Aug; 16(8):990-8. PubMed ID: 15744453
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials.
Liu J; Ho SC; Su YX; Chen WQ; Zhang CX; Chen YM
Bone; 2009 May; 44(5):948-53. PubMed ID: 19168161
[TBL] [Abstract][Full Text] [Related]
7. Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: meta-analysis of randomized controlled trials.
Taku K; Melby MK; Takebayashi J; Mizuno S; Ishimi Y; Omori T; Watanabe S
Asia Pac J Clin Nutr; 2010; 19(1):33-42. PubMed ID: 20199985
[TBL] [Abstract][Full Text] [Related]
8. Effects of Oestrogen Treatment on Skeletal Response to Exercise in the Hips and Spine in Postmenopausal Women: A Meta-Analysis.
Zhao R; Xu Z; Zhao M
Sports Med; 2015 Aug; 45(8):1163-73. PubMed ID: 26003475
[TBL] [Abstract][Full Text] [Related]
9. Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia.
Chuengsamarn S; Rattanamongkoulgul S; Suwanwalaikorn S; Wattanasirichaigoon S; Kaufman L
Bone; 2010 Apr; 46(4):1011-5. PubMed ID: 20045497
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitors and the risk of vertebral fracture.
Schoofs MW; Sturkenboom MC; van der Klift M; Hofman A; Pols HA; Stricker BH
J Bone Miner Res; 2004 Sep; 19(9):1525-30. PubMed ID: 15312254
[TBL] [Abstract][Full Text] [Related]
11. The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis.
Zhao R; Zhao M; Xu Z
Osteoporos Int; 2015 May; 26(5):1605-18. PubMed ID: 25603795
[TBL] [Abstract][Full Text] [Related]
12. Jumping improves hip and lumbar spine bone mass in prepubescent children: a randomized controlled trial.
Fuchs RK; Bauer JJ; Snow CM
J Bone Miner Res; 2001 Jan; 16(1):148-56. PubMed ID: 11149479
[TBL] [Abstract][Full Text] [Related]
13. Antiresorptive agents increase the effects of exercise on preventing postmenopausal bone loss in women: a meta-analysis.
Zhao R; Xu Z; Zhao M
PLoS One; 2015; 10(1):e0116729. PubMed ID: 25615597
[TBL] [Abstract][Full Text] [Related]
14. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
[TBL] [Abstract][Full Text] [Related]
15. Lower femoral neck bone mineral density (BMD) in elderly women not on statins.
Chiadika SM; Shobayo FO; Naqvi SH; Saraykar SS; Ambrose CG; Rianon NJ
Women Health; 2019 Sep; 59(8):845-853. PubMed ID: 30721115
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density.
Shin CS; Choi HJ; Kim MJ; Kim JT; Yu SH; Koo BK; Cho HY; Cho SW; Kim SW; Park YJ; Jang HC; Kim SY; Cho NH
Bone; 2010 Aug; 47(2):378-87. PubMed ID: 20362081
[TBL] [Abstract][Full Text] [Related]
17. Relation of statin use and bone loss: a prospective population-based cohort study in early postmenopausal women.
Sirola J; Sirola J; Honkanen R; Kröger H; Jurvelin JS; Mäenpää P; Saarikoski S
Osteoporos Int; 2002 Jul; 13(7):537-41. PubMed ID: 12111013
[TBL] [Abstract][Full Text] [Related]
18. Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women.
Tanriverdi HA; Barut A; Sarikaya S
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):63-8. PubMed ID: 15866088
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness of Combined Exercise Interventions for Preventing Postmenopausal Bone Loss: A Systematic Review and Meta-analysis.
Zhao R; Zhang M; Zhang Q
J Orthop Sports Phys Ther; 2017 Apr; 47(4):241-251. PubMed ID: 28257620
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of resistance exercise on lumbar spine and femoral neck bone mineral density in premenopausal women: a meta-analysis of individual patient data.
Kelley GA; Kelley KS
J Womens Health (Larchmt); 2004 Apr; 13(3):293-300. PubMed ID: 15130258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
